Evidence map›Paper›PMID 30378151›Full record

Trial reportBritish journal of clinical pharmacology2019

The role of vascular endothelium in nitroglycerin-mediated vasodilation.

Kangbin Zhou, John D Parker

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. The role of vascular endothelium in nitroglycerin-mediated vasodilation.British journal of clinical pharmacology · 2019
    Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Impact of the Post-Thrombotic Syndrome on the Arterial Wall of the Lower Limbs.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kangbin ZhouDepartment Pharmacology and Toxicology, the University of Toronto.ORCID 0000-0002-5266-3717
John D ParkerDepartment Pharmacology and Toxicology, the University of Toronto.
University Health Network · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

aimsNitroglycerin (or glyceryl trinitrate, GTN) has been long considered an endothelium-independent vasodilator because GTN vasodilation is intact in the absence of the endothelium and in the presence of endothelial dysfunction. However, in animal and in vitro models, GTN has been shown to stimulate the release of certain endothelium-derived vasodilators such as nitric oxide (NO) and prostacyclin (PGI

methodsWe examined the effect of inhibition of NO, PGI

resultsOur results demonstrate that inhibition of endothelium-dependent vasodilator mechanisms does not alter forearm resistance vessel responses to GTN.

conclusionWe conclude that GTN-mediated dilation of forearm resistance vessels is largely independent of vascular endothelium.

Indexed as

AdolescentAdultAnimalsEndothelium, VascularEpoprostenolFemaleForearmHealthy VolunteersHumansMaleNitric OxideNitroglycerinPilot ProjectsRegional Blood FlowVascular ResistanceVasodilationEpoprostenolNitric OxideNitroglycerinVasodilator Agentscardiovascular pharmacologyendotheliumnitric oxidepharmacokinetic-pharmacodynamic

Identifiers

PMID30378151
PMCPMC6339986
OpenAlexW2899335053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.